- Trials with a EudraCT protocol (495)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
495 result(s) found for: Social control.
Displaying page 1 of 25.
EudraCT Number: 2009-015538-30 | Sponsor Protocol Number: OXTsozphob | Start Date*: 2010-04-21 | |||||||||||
Sponsor Name:Rheinisch-Westfälisch Technische Hochschule Aachen | |||||||||||||
Full Title: Effect of intranasal oxytocin on social approach in patients with social phobia and healthy control | |||||||||||||
Medical condition: The effect of oxytocin is investigated in social processing of social phobic patient and healthy controls | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023007-10 | Sponsor Protocol Number: TF2010 | Start Date*: 2011-03-22 | |||||||||||
Sponsor Name:Uppsala university | |||||||||||||
Full Title: A neuroscience perspective on anxiety proneness - Sex differences, monoaminergic pathways and treatment response | |||||||||||||
Medical condition: Men and women diagnosed with DSM-IV social phobia (social anxiety disorder) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003597-10 | Sponsor Protocol Number: CRH103390 | Start Date*: 2006-11-04 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development | |||||||||||||
Full Title: Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD) | |||||||||||||
Medical condition: Social Anxiety Disorder (SocAD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FI (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006126-25 | Sponsor Protocol Number: 06 038 | Start Date*: 2007-06-08 |
Sponsor Name:CNRS: VAN DER REST Michel | ||
Full Title: Emotional and Social deficits in Asperger syndrome | ||
Medical condition: We investigate the Asperger Syndrome, it's a pervasive developmental condition related to autism. It manifests in highly individual ways and can have both positive and negative effects on a person.... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000258-64 | Sponsor Protocol Number: D1449L00004 | Start Date*: 2005-04-08 |
Sponsor Name:AstraZeneca AB | ||
Full Title: SCORE An open, randomised, parallel, three treatment groups, multicentre, phase IV study - in real life - to compare the change in social outcome of quetiapine fumarate (Seroquel®) combined with Co... | ||
Medical condition: Schizophrenia is a chronic psychiatric disorder that often begins during adolescence or early adulthood. A major problem for patients with schizophrenia is a cognitive deficit compared to a control... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-001552-18 | Sponsor Protocol Number: A1481307 | Start Date*: 2019-07-26 | |||||||||||
Sponsor Name:Pfizer, Inc. | |||||||||||||
Full Title: A LOCAL, SINGLE-CENTRE, EXTENSION, OPEN LABEL ACCESS STUDY, TO PROVIDE SILDENAFIL THERAPY FOR SUBJECTS WHO COMPLETED A1481156 STUDY AND ARE JUDGED BY THE INVESTIGATOR TO DERIVE CLINICAL BENEFIT FRO... | |||||||||||||
Medical condition: pulmonary atrial hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003331-10 | Sponsor Protocol Number: HC03 | Start Date*: 2017-10-16 |
Sponsor Name:Leiden University | ||
Full Title: Acute effects of 40 mg cortisol on emotion and cognition. | ||
Medical condition: None. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-005239-15 | Sponsor Protocol Number: MISO | Start Date*: 2016-08-12 |
Sponsor Name:Charité - Universitätsmedizin Berlin | ||
Full Title: Effects of mineralocorticoid receptor stimulation on cognitive bias and social cognition in patients with major depression and healthy controls: what’s the role of NMDA receptors? | ||
Medical condition: depressed patients and healthy control subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-022463-35 | Sponsor Protocol Number: 3.1 | Start Date*: 2011-07-08 |
Sponsor Name:Manchester Mental Health and Social Care Trust | ||
Full Title: The Benefit of Minocycline on Negative Symptoms in Psychosis: Extent and Mechanisms | ||
Medical condition: schizophrenia | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-003851-41 | Sponsor Protocol Number: Bumetanide/Autism | Start Date*: 2021-11-08 |
Sponsor Name:Gillberg Neuropsychiatry Centre | ||
Full Title: A Randomized Waitlist-Control Trial with Bumetanide in Children with Autism | ||
Medical condition: Autism spectrum disorder, a neurodevelopmental disorder with onset in childhood. The disorder implies deficits in social and communicative abilities and restricted interests and behaviors. Many chi... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003529-41 | Sponsor Protocol Number: ABR58805 | Start Date*: 2017-02-22 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: CANGLIA: Endocannabinoid control of microglia activation as a new therapeutic target in the treatment of schizophrenia | ||
Medical condition: Schizophrenia patients | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-010584-16 | Sponsor Protocol Number: 2009/001 | Start Date*: 2010-10-25 | |||||||||||||||||||||
Sponsor Name:ZonMw | |||||||||||||||||||||||
Full Title: New pharmacotherapeutic treatment options for crack-cocaine dependent people in the Netherlands. | |||||||||||||||||||||||
Medical condition: Crack-cocaine dependence (according to DSM-IV) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-006244-73 | Sponsor Protocol Number: EC11-387 | Start Date*: 2012-05-29 |
Sponsor Name:Instituto Aragonés de Ciencias de la Salud | ||
Full Title: Evaluation of the efficacy of memantine in the treatment of fibromyalgia: a double-blind randomized control clinical trial. | ||
Medical condition: Fibromyalgia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001855-20 | Sponsor Protocol Number: Driving07 | Start Date*: 2009-02-03 |
Sponsor Name:Faculty of Social Sciences, Utrecht University | ||
Full Title: A double blind placebo controlled crossover study to determine the effects of atomoxetine on event-related potentials in response to auditory oddball stimuli during an on-the-road driving test in a... | ||
Medical condition: The effects of atomoxetine on driving performance, attention and response inbihition are studied in adult patients with attention-deficit hyperactivity disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019360-36 | Sponsor Protocol Number: 10015LH-OPMS | Start Date*: 2010-05-26 |
Sponsor Name:Belfast Health and Social Care Trust | ||
Full Title: Pilot study of treatment of depression in refractory asthma | ||
Medical condition: Refractory Asthma Depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-005088-82 | Sponsor Protocol Number: CAFQ056A2204 | Start Date*: 2008-05-15 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multi-centre, randomized, double-blind, placebo-controlled, two-period, crossover proof-of-concept study in patients with Fragile X Syndrome to assess the efficacy, safety and tolerability of mul... | |||||||||||||
Medical condition: Fragile X Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001244-15 | Sponsor Protocol Number: D22-P006 | Start Date*: 2023-01-12 |
Sponsor Name:GHU Paris Psychiatrie et Neurosciences | ||
Full Title: Efficiency of a composite personalised care on functional outcome in early psychosis: A Prospective Randomised Controlled Trial - PsyCARE_Trial | ||
Medical condition: early psychosis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004383-23 | Sponsor Protocol Number: RISSCH4055 | Start Date*: 2005-11-24 |
Sponsor Name:Janssen Cilag Ltd | ||
Full Title: Pragmatic randomized trial of Risperdal Consta versus oral atypical antipsychotics in poorly adherent subjects with schizophrenia ina routine care setting. Protocol RISSCH4055; Phase IV (risperid... | ||
Medical condition: Schizophrenia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) IE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2004-000954-22 | Sponsor Protocol Number: CI-1008-100 | Start Date*: 2004-09-23 |
Sponsor Name:Pfizer Global Research & Development | ||
Full Title: A 1-Year Open-Label Safety Extension Study of Pregabalin (CI-1008) in Patients With Anxiety Disorders | ||
Medical condition: Generalized Anxiety Disorder | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-004689-42 | Sponsor Protocol Number: RGHT000298 | Start Date*: 2008-07-29 |
Sponsor Name:Belfast Health and Social Care Trust | ||
Full Title: Insulin action and hypertension: effects of hyperaldosteronism and its treatment. | ||
Medical condition: The effect of eplerenone on insulin action is being studied in patients with mild essential hypertension. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
